IJCS | Volume 33, Nº1, January / February 2019

67 1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis A, Kenneth A, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation -- executive summary: a report of theAmericanCollege of Cardiology/AmericanHeartAssociation Task Force on PracticeGuidelines and the European Society of CardiologyCommittee for PracticeGuidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Arial Fibrillation). J Am Coll Cardiol 2007;50(6):562 2. Birman-Deych E, Radford MJ, Nilasena DS, Gage BF. Use and effectiveness of warfarin inMedicare beneficiaries with atrial fibrillation. Stroke 2006;37(4):1070-4. 3. Heidbuchel H, Verhamme P, Alings M, Camm AJ. Updated European Heart RhythmAssociation practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary. ESC Scientific Document Group. Eur Heart J. 2017 Jul 14; 38(27): 2137–49. 4. Magalhães LP, Figueiredo MJ, Cintra FD. Executive Summary of the II Brazilan Guidelines for Atrial Fibrillation.II Brazilian Guidelines for Atrial Fibrillation. Arq Bras Cardiol.2016;107(6):501-8. 5. Kirchhof P, Benussi S, Kotecha D, (Task force members). 2016 Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016; 37(38): 2893–962. 6. January CT, Wann S, Calkins H, Chen LY, Cigarroa JE, Cleveland Jr JC, et al. 2019 Focused Update on Atrial Fibrillation. 2019 AHA/ACC/ HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Circulation. 2019; 140(2):e125-e151. 7. Geraldes MFA, Darze ES, Rocha PN. Trends and predictors of oral anticoagulation in patients with atrial fibrillation: a serial cross-sectional study from 2011 to 2016. Int J Cardiovasc Sci. 2020;33(1):68-78. 8. Marzec LN, Wang J, Shah, Chan PS, Ting HH, Gosch KL, et al. Influence of direct oral anticoagulants on rates of oral anticoagulation for atrial fibrillation. J Am Coll Cardiol. 2017;69(20):2475-83. 9. Monelli M, Molteni M, Cassetti G, Bagnara L, Del Grazia V, Zingale L, et al. Non- Vitamin K oral anticoagulante use in the elderly: a prospective real-world study – data from the REGIstry of patients on Non-vitamin K oral anticoagulants (REGINA). Vasc Health Manag. 2019;15:19-25. 10. Fosbol L, Holmes DN, Piccin JP, Hplmes DN, Piccini JP, Thomas L, Reiffel JA, Mills RN, et al. Provider specialty and atrial fibrillation treatment strategies inUnited States Community practice: findings from the ORBIT- AF registry. J Am Heart Assoc. 2013;2(4):e000110. References Bronchtein et al. Anticoagulation in atrial fibrillation Int J Cardiovasc Sci. 2020;33(1):65-67 Editorial This is an open-access article distributed under the terms of the Creative Commons Attribution License